Max Chat
Matinas BioPharma Holdings, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 52.65 | -100% | -9.07 | -100% |
| P/S |
|
43.41 | 4.03 | 976.54% |
|
|
| P/BV |
|
0.3321 | 10.87 | -96.94% |
|
|
| P/FCF |
|
0 | 39.64 | -100% |
|
|
| Ev/Ebitda |
|
0.08 | 16.12 | -99.5% |
|
|
| Ev/S |
|
-1.71 | 4.35 | -139.2% |
|
|
| Ev/FCF |
|
0.1177 | 52.31 | -99.78% |
|
|
| E/P |
|
0 | 0.2095 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-2131.3 | 19.07 | -11275.69% | -19826.15 | -89.25% |
| ROE |
|
-180.73 | -83.32 | 116.91% |
|
|
| ROA |
|
-128.5 | 6.38 | -2114.5% |
|
|
| ROIC |
|
0 | 15.06 | -100% |
|
|
| ROS |
|
-2212.68 | 9.34 | -23802.58% |
|
|
| ROCE |
|
-313.12 | 67.03 | -567.14% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1239 | 1.02 | -112.17% | -0.1508 | -17.86% |
| Nеt Debt/Ebitda |
|
0.1879 | 1.4 | -86.57% |
|
|
| Debt/Ratio |
|
0.2289 | 0.2741 | -16.47% |
|
|
| Debt/Equity |
|
0.6655 | 13.6 | -95.11% |
|
|
| Debt/Net Income |
|
-0.1193 | 6.8 | -101.76% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.28 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 6.75 | -100% | ||
| DSI |
|
0 | 0.7413 | -100% |
|
|
| Average dividend growth |
|
0 | -4.1 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.34 | -100% |
|
|
| Average percentage for payments |
|
0 | 44.08 | -100% |
|
|
| Difference from average difference in sector |
|
-1.28 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
1117.78 | 12.47 | 8863.75% | ||
| Growth impulse Ebitda in 5 years |
|
-7.67 | -86.3 | -91.11% | ||
| Growth impulse Net Income in 5 years |
|
17.72 | -75.86 | -123.36% | ||
| Growth impulse FCF in 5 years |
|
-8.71 | -79.28 | -89.01% | ||
| Growth impulse EPS in 5 years |
|
4664.76 | 4.34 | 107382.95% |
IP Score
3.91/10
